|
|
|
Volumn , Issue 104, 2007, Pages 1-8
|
|
Pharmacogenomics and warfarin therapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
MIXED FUNCTION OXIDASE;
UNSPECIFIC MONOOXYGENASE;
WARFARIN;
ARTICLE;
BLEEDING;
CANADA;
CHEMICALLY INDUCED DISORDER;
COST;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
INTERNATIONAL NORMALIZED RATIO;
PACKAGING;
PHARMACOGENETICS;
PRACTICE GUIDELINE;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
UNITED STATES;
ANTICOAGULANTS;
ARYL HYDROCARBON HYDROXYLASES;
CANADA;
COSTS AND COST ANALYSIS;
DEVICE APPROVAL;
HEMORRHAGE;
INTERNATIONAL NORMALIZED RATIO;
MIXED FUNCTION OXYGENASES;
PHARMACOGENETICS;
PRACTICE GUIDELINES;
PRODUCT LABELING;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
WARFARIN;
|
|
EID: 35148814872
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
